RT Journal Article
SR Electronic
T1 How COVID-19 interacts with interstitial lung disease
JF Breathe
JO Breathe
FD European Respiratory Society
SP 210158
DO 10.1183/20734735.0158-2021
VO 18
IS 1
A1 Myall, Katherine J.
A1 Martinovic, Jennifer L.
A1 West, Alex
YR 2022
UL http://breathe.ersjournals.com/content/18/1/210158.abstract
AB The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had far-reaching impacts on patients with interstitial lung disease (ILD), from diagnosis to management. In addition, after infection, persistent parenchymal change is associated with ongoing symptoms and functional impairment even in patients without pre-existing lung disease. The challenge of investigating and treating these patients has often fallen to ILD physicians. This review therefore seeks to explore the relationship between COVID-19 and the interstitium, as well as the model of care for patients with pre-existing ILD and those patients with persistent disease following recovery from their initial infection.Educational aimsTo understand the impact of the COVID-19 pandemic on patients with existing interstitial lung disease.To explore the development of interstitial lung disease after COVID-19 infection.COVID-19 has had profound effects on patients with pre-existing interstitial lung disease, and there is growing interest in the effect on the lung parenchyma in patients recovering from acute infection. https://bit.ly/33M5s4x